PR Newswire
reports that Merck Serono, a division of the German pharma giant Merck KGaA, has signed a distribution agreement with Bristol-Myers Squibb for a portfolio of established pharmaceutical brands in Latin America.
This agreement gives Merck Serono the exclusive marketing and distribution rights to more than 30 prescription medicines, particularly in the cardio-metabolic field, in Argentina, Chile, Colombia, Ecuador, Panama, Peru and Venezuela. Sales of these medicines last year topped US$90 million. Products featured in the deal include well-established brands such as Pravachol for the treatment of high cholesterol levels and Monopril, an ACE-inhibitor used in the field of hypertension.
PR Newswire reports that Merck Serono, a division of the German pharma giant Merck KGaA, has signed a distribution agreement with Bristol-Myers Squibb for a portfolio of established pharmaceutical brands in Latin America.
This agreement gives Merck Serono the exclusive marketing and distribution rights to more than 30 prescription medicines, particularly in the cardio-metabolic field, in Argentina, Chile, Colombia, Ecuador, Panama, Peru and Venezuela. Sales of these medicines last year topped US$90 million. Products featured in the deal include well-established brands such as Pravachol for the treatment of high cholesterol levels and Monopril, an ACE-inhibitor used in the field of hypertension.
![[Interview] How does Mercado Libre deal with online IP infringements?](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEilexoWfiRujjpmd-Um4qIlawa0S8iWZ5i2EuqzJcCIyJs5srOU5br7y44YJkp0g5t8lBLAo5s5Gte-j0yg5M5cJ_wqLtTxY-ej8kzblVdoFHFsXxyLLHQeT7qtPQcDBqRWt0KfTHOh37sd/s72-c/Banner+BPP.jpg)
